Potential biomarkers develop for predicting the prognosis of patients with esophageal squamous cell carcinoma after optimized chemoradiotherapy using serum metabolomics

Abstract Background Esophageal squamous cell carcinoma (ESCC), the most common type of esophageal cancer, characterized by low five-year survival rate, and concurrent chemoradiotherapy (CCRT) has been proposed to treat ESCC, while potential biomarkers for prognostic monitoring after optimized CCRT r...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Jie Yang, Yunyun Zhu, Yijian Zhou, Jiaying Zhang, Yuxuan Wei, Yongpan Liu, Bo Zhang, Jialing Xie, Xiaolu An, Xianhua Qi, Yuting Yue, Lijia Zhang, Xiajun Zhang, Zhichao Fu, Kuancan Liu
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	BMC 2025-03-01
Cyfres:	BMC Cancer
Pynciau:	Esophageal squamous cell carcinoma Metabolomics CCRT Prognosis Biomarkers
Mynediad Ar-lein:	https://doi.org/10.1186/s12885-025-13866-x
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!